Alcalá, Sonia
Villarino, Lara
Ruiz-Cañas, Laura
Couceiro, José R.
Martínez-Calvo, Miguel
Palencia-Campos, Adrián
Navarro, Diego
Cabezas-Sainz, Pablo
Rodriguez-Arabaolaza, Iker
Cordero-Barreal, Alfonso
Trilla-Fuertes, Lucia
Rubiolo, Juan A.
Batres-Ramos, Sandra
Vallespinos, Mireia
González-Páramos, Cristina
Rodríguez, Jéssica
Gámez-Pozo, Angelo
Vara, Juan Ángel Fresno
Fernández, Sara Fra
Berlinches, Amparo Benito
Moreno-Mata, Nicolás
Redondo, Ana María Torres
Carrato, Alfredo
Hermann, Patrick C.
Sánchez, Laura
Torrente, Susana
Fernández-Moreno, Miguel Ángel
Mascareñas, José L.
Sainz, Bruno Jr. http://orcid.org/0000-0003-4829-7651
Funding for this research was provided by:
Fundación Fero
Ministerio de Ciencia e Innovación (RYC-2012-12104, PID2019-110320RB-I00, PID2019-108624RB-I00, PDC2021-121508-I00, CTQ2016-81797-REDC)
AESPANC-ACANPAN
Concern Foundation
Fundación Científica Asociación Española Contra el Cáncer (GC16173694BARB, IDEAS222917FERN)
Instituto de Salud Carlos III (PI18/00757, PI21/01110, PT20/00045)
H2020 European Research Council (340055, 899334)
Deutsche Kinderkrebsstiftung (111746)
Deutsche Bundesstiftung Umwelt (CRC 1279)
Agencia Gallega de Innovación (IN855A-2018/16)
'la Caixa' Foundation (CC21-20122)
Consejo Superior de Investigaciones Cientificas
Article History
Received: 15 October 2023
Accepted: 11 December 2023
First Online: 27 January 2024
Declarations
:
: All patients signed a written informed consent for donation of samples for research under the regimen of the Ramón y Cajal University Hospital Biobank. The study was submitted to the Ethical Investigation Committee of the Ramón y Cajal University Hospital Biobank and was approved in 2022 (Dictum 140/22 and 280/22).
: A.G-P and J.A.F.V. are shareholders of Biomedica Molecular Medicine SL. The <i>Ru1</i> compound intellectual property is published as EP3539971 B1.